Objectives: To evaluate the outcomes of robotic partial nephrectomy compared with those of laparoscopic partial nephrectomy for T1 renal tumors in Japanese centers. Methods: Patients with a T1 renal tumor who underwent robotic partial nephrectomy were eligible for inclusion in the present study. The primary end-point consisted of three components: a negative surgical margin, no conversion to open or laparoscopic surgery and a warm ischemia time ≤25 min. We compared data from these patients with the data from a retrospective study of laparoscopic partial nephrectomy carried out in Japan. Results: A total of 108 patients were registered in the present study; 105 underwent robotic partial nephrectomy. The proportion of patients who met the primary end-point was 91.3% (95% confidence interval 84.1-95.9%), which was significantly higher than 23.3% in the historical data. Major complications were seen in 19 patients (18.1%). The mean change in the estimated glomerular filtration rate in the operated kidney, 180 days postoperatively, was À10.8 mL/min/1.73 m 2 (95% confidence interval À12.3-9.4%). Conclusions: Robotic partial nephrectomy for patients with a T1 renal tumor is a safe, feasible and more effective operative method compared with laparoscopic partial nephrectomy. It can be anticipated that robotic partial nephrectomy will become more widely used in Japan in the future.
Introduction
Two decades ago, the standard treatment for T1 renal cancer was radical nephrectomy (in patients who did not have contralateral renal function impairments). However, radical nephrectomy can be associated with an increased risk of developing chronic kidney disease, as well as an increased cardiovascular morbidity and mortality. [1] [2] [3] Open partial nephrectomy and LPN have been shown to have similar efficacy as radical nephrectomy. 4, 5 The National Comprehensive Cancer Network and European Association of Urology recommend partial nephrectomy in tumors with a diameter ≤7 cm, when feasible. 6, 7 Open partial nephrectomy is more invasive than LPN. Furthermore, LPN requires the surgeon to have a high level of skill and significant training to become proficient in the technique. Recently, robotic surgery has become more commonly used. RPN enables minute tumor excision in a limited space, detachment and kidney suture, with low aggression. Additionally, this procedure is less invasive and tends to have less interoperator variation. Several previous studies have shown the usefulness of RPN, proven in terms of warm ischemia time and blood loss. [8] [9] [10] Since the report by Shiroki et al. was published, RPN has been carried out in Japan; however, there is still little evidence to show that the technique is more useful than LPN. 11 The purpose of the present study was to evaluate the efficacy and safety of RPN in a prospective study, comparing this technique with a historical control study of patients who had undergone LPN in Japan. 12 
Methods

Study design
This prospective study had a multicenter, single-arm, openlabel design.
For the historical control data, we referred to the results from an observational study by Saito et al., involving 54 facilities and 1375 patients who underwent LPN between 1998 and 2008, in Japan. 12 We chose this specific study because it was the largest-scale study of LPN in Japan, and we considered their data reliable and representative for LPN in the Japanese medical environment. The study was divided into three groups according to the relevant time period 
Setting
We carried out this study in 14 domestic facilities. The study protocol (KBU-SENB-0001) was approved by the ethical review board at each participating facility and conformed to the provisions of the revised Declaration of Helsinki. The prospective part of this study began in September 2014 and is currently ongoing, as it continues to examine the duration of survival. We included the data from all patients enrolled in the study up until May 2016 (allowing for a follow-up period of at least 1 year).
Participants (inclusion and exclusion criteria)
We targeted patients with renal tumors ≤7 cm long, without lymph node metastases or remote metastasis. The inclusion criteria were as follows: patients in whom cT1 kidney cancer was diagnosed and partial nephrectomy was possible; no lymph node metastases and no metastases in another organ in the abdominal cavity (i.e. patients with isolated tumors); white blood cell count ≥3000/lL, platelet count ≥10 9 10 4 /lL, aspartate aminotransferase level ≤100 IU/L, alanine transaminase level ≤100 IU/L, total bilirubin level ≤2.0 mg/dL and serum creatinine level ≤2.0 mg/dL within 6 weeks before registration; and age ≥20 years at the time of enrollment.
We excluded patients if their condition overlapped with other cancers, with a history of renal transplantation, treated for kidney cancer within 6 months, for whom anticoagulants were not discontinued, with anemia that required a blood transfusion, with a bleeding tendency, with a body mass index ≥35 kg/m 2 and undergoing dialysis. We also excluded patients who did not comply with the study protocol.
Surgical technique
We used either the da Vinci-S surgical system or the da Vinci-Si surgical system (Intuitive Surgical, Sunnyvale, CA, USA) in this study. The surgical techniques have been described in a previous study 13 and the techniques were specified in the protocol. 13 A three-arm or four-arm technique was used in both the transperitoneal and retroperitoneal approaches.
Outcomes
The primary end-point of our study consisted of three components: (i) a negative surgical margin; (ii) no conversion to open or laparoscopic surgery; and (iii) warm ischemia time ≤25 min. For partial nephrectomy, a warm ischemia time ≤25 min is shown to be particularly effective in preserving kidney function. 14 The eGFR, over a 1-year follow-up period, was evaluated as the secondary end-point. As the eGFR is normally used to evaluate the function of both kidneys, this measure did not allow us to evaluate the function of the operated kidney separately. Therefore, we also evaluated pre-and postoperative changes in eGFR of the operated kidney using the percentage of the operated kidney to both kidneys with renal scintigraphy (eGFR 9 split [%] for the operated kidney). 15 The total operative time, operative blood loss and console time were also measured as perioperative outcomes.
In assessing safety outcomes, we recorded serious adverse events using the Clavien-Dindo classification. 16 Serious adverse events in this study were defined as events that: (i) resulted in death; (ii) were life-threatening; (iii) required inpatient hospitalization or prolonged hospitalization; (iv) resulted in persistent or significant disability or incapacity; or (v) were another serious medical condition.
Sample size
The planned sample size was 100 patients. This number was chosen because the proportion of patients undergoing LPN with a warm ischemia time ≤25 min was not anticipated to be >25%, based on the historical control study. 12 In the cases involving RPN, we expected the proportion of patients with a warm ischemia time ≤25 min to be approximately 40%. The proportions of patients with a negative surgical margin and without transition to open or laparoscopic partial nephrectomy were anticipated to be 98% and 95%, respectively, for those undergoing both LPN and RPN. The null hypothesis, H 0 , and the alternative hypothesis, H 1 , for the primary endpoint were set as follows: H 0 , 23.3% (=25% 9 98% 9 95%); and H 1 , 37.2% (=40% 9 98% 9 95%). Under these conditions, the required sample size was 93, based on the exact binomial test with a 5% significance level and 80% power.
Statistical analysis
An exact binomial test with a significance level of 5% for 23.3% of the null hypothesis, H 0 , was carried out, and the proportion and its 95% CI were calculated for the primary end-point. The proportion and its 95% CI, and the mean and its 95% CI, were calculated for dichotomous and continuous outcomes, respectively.
Results
Patients
In the present study, 108 patients were registered (Fig. 1) . Five patients were excluded, because they did not satisfy the inclusion criteria. The full analysis set consisted of 103 patients, three of whom did not undergo RPN. Table 1 shows the patients' background characteristics. All patients elected to undergo partial nephrectomy. Regarding the variables, there were no meaningful differences between this study and the observational study (which we referred to as the historical control). The RENAL nephrometry score was not assessed in the observational study. 17 There was also no meaningful difference between the two groups regarding operative time (Table 2 ).
Primary end-point
A total of 94 of the 103 patients (91.3%, 95% CI 84.1-95.9%) had a warm ischemia time ≤25 min, negative surgical margin and did not undergo conversion to open or laparoscopic surgery. Figure 2 shows the proportion and 95% CI for the primary end-point, with the null hypothesis value of 23.3% shown as the dashed line. The P-value was <0.0001 in the exact binomial test, which was significantly greater than the null hypothesis value of 23.3%. Table 3 shows each component of the primary end-point. None had a positive surgical margin or underwent conversion to laparoscopic or open surgery. Figure 3 shows the change in the total eGFR over the 365-day follow-up period. Figure 4 presents a scatter plot of the eGFR of the operated kidneys, which was estimated using kidney scintigraphy preoperatively and at 180 days postoperatively. The mean change in the eGFR in the operated kidneys, 180 days postoperatively, was À10.8 mL/min/1.73 m 2 (95% CI À12.3-9.4%). The stages of chronic kidney disease did not change in 44 of the patients over the 180-day followup period. A total of 46 patients regressed by one stage, and six patients regressed by two stages over this period.
Secondary end-points
Complications
No deaths occurred in the present study. There were 19 serious adverse events reported over the 365-day postoperative follow-up period (Table 4) . Furthermore, eight of the adverse events were operation-related, whereas the other 11 adverse events were not. The da Vinci system malfunctioned in two patients: one due to bipolar tip damage, and in the other case, the 3-D display did not turn on. These issues were quickly fixed, and they did not affect the results.
Discussion
In partial nephrectomy, a warm ischemia time ≤25 min has been reported to reduce the onset of renal failure and chronic renal disease. 14, 18 Other important factors in evaluating the efficacy of RPN are whether there is conversion to open or laparoscopic surgery and whether an excision stump remains postoperatively. Therefore, the primary endpoint of this study consisted of these three factors combined. The present study showed that the proportion of patients who met the primary end-point was 91.3% (95% CI 84.1-95.9%). This result was significant and exceeded 23.3%, which we set as the historical control (Fig. 2) .
Hence, our findings suggest that RPN is superior to LPN in terms of efficacy.
Initially, we thought that if the proportion of patients with a warm ischemia time ≤25 min improved by 10% in the RPN cases, compared to the LPN cases, it would be clinically significant. Considering the costs associated with RPN, we later concluded that a 15% improvement in warm ischemia time was required. Consequently, we expected a proportion rate of 37.2% for the primary end-point. However, the estimated proportion of this primary end-point was much greater at 91.3%, indicating the usefulness of RPN.
No patient underwent conversion to open or laparoscopic surgery or had an excision stump. Therefore, we can interpret the value, 91.3%, of the primary end-point consisting of three components as the value of only the ischemia time ≤25 min. According to Funahashi et al., patients who underwent open partial nephrectomy in Japan and had a warm ischemia time ≤25 min were less likely to have renal function impairment than those with a warm ischemia time >25 min. 18 Therefore, a warm ischemia time of ≤25 min is important, and the present study shows that preservation and maintenance of renal function with RPN are excellent.
The eGFR was used to evaluate renal function. The change in eGFR, 1 year postoperatively, was approximately 10%, which was similar to that in previous reports. 10, 19 Additionally, we used kidney scintigraphy, 180 days preand postoperatively, to evaluate the function of the operated kidneys. The reduction in eGFR in the operated kidneys, 180 days postoperatively, averaged 10 mL/min/1.73 m 2 , and these values were independent of preoperative eGFR. The scatter plot in Figure 4 includes additional lines relating to the grade of chronic kidney disease. Regarding the decrease in eGFR in the operated kidney, many patients remained in the same classification grade or decreased by only one grade. Just 6% (6/100) of patients decreased by two classification grades.
Most of the serious adverse events reported in the present study were pseudoaneurysms. One study reported that asymptomatic pseudoaneurysms were confirmed with contrast-computed tomography in 15% (17/117) of patients who underwent RPN. 20 However, even if small pseudoaneurysms develop, they tend to resolve naturally. Therefore, the onset of symptomatic pseudoaneurysms was approximately 10%. Similarly, pseudoaneurysms were seen in seven patients in the present study (6.7%). In the protocol of this study, the surgeon was required to have carried out LPN or open partial nephrectomy in ≥10 cases. Furthermore, they were required to have carried out >20 cases of robot-assisted radical prostatectomy and ≥10 cases of RPN. This number is still achievable in facilities in which a high volume of robotic surgery is not carried out. It is possible to achieve skills in robot-assisted surgery in a short period of time, although this technique requires constant training and technical experience. Furthermore, reports have shown the usefulness of robotic surgery to treat highly complex tumors. 21, 22 Based on the results of the present study, we suggest that RPN is useful in treating highly complex tumors that are difficult to treat laparoscopically, such as hilar and central tumors.
The main limitation of the present study was that we did not use a concurrent control group. The historical control LPN data might be weakened owing to the diversity of the surgeons' experience with the technique. Many studies have compared RPN with LPN, 9 but a randomized controlled trial has not been carried out, as it is difficult to carry out in the clinical setting. Ideally, a prospective non-randomized study should be carried out for comparing RPN with LPN. However, as conducting such study was not feasible at the planning stage of this study, we chose to use a historical control. Even if we proceeded with the prospective non-randomized study, we would still need to carefully discuss the unmeasured confounding factors for the selection of RPN and LPN. Although we did not find large differences in the patient background characteristics between the present study and the historical control data, the relevance of the selected historical control might be questioned. Choi et al. reported a systematic review of the comparison between RPN and LPN, although the study did not include data from Japan. 9 They reported that, in RPN, the average warm ischemia time was shorter, and the risk of conversion to open surgery and radical nephrectomy was smaller in comparison with LPN. There was no large difference observed for the stump-positive rate. As for the warm ischemia time, the average time for LPN among studies ranged from 22 to 36.4 min, whereas that for RPN in the present study was 19.0 min (Table 2) , and this value was shorter compared with those LPN studies. Another limitation was that the patients in the historical control, which consisted of numerous institutions and surgeons during early and immature phases, did not have the same background as those in the present prospective study. However, there were no meaningful differences in terms of patient background between the two studies ( Table 1 ). The influence of time was also a confounding factor in the present study, as we used a historical control. Recently, shortening of the warm ischemia time has been shown in LPN. 23 The warm ischemia time of LPN in the present day might be short compared with that in the historical control. Therefore, the primary end-point value of 23.3% for patients undergoing LPN might actually be low. In studies in Japan, the mean warm ischemia time for patients undergoing LPN was almost 20-30 min. 24, 25 Of these studies, Osaka et al. reported that 64% (42/63) of patients had a warm ischemia time ≤25 min. 25 In the present study, the mean warm ischemia time was 19 min. For these cases involving RPN, even if we use the lower limit of the 95% CI to estimate the proportion of patients with a warm ischemia time of ≤25 min, it is still quite high at 84.1%. Thus, although we consider that the value in the historical control might be undervalued, we can show the efficacy of RPN, even if we consider the influence of the bias by various factors such as this. There were just 103 patients in the present study, which is much smaller than the number in the historical control (1375 patients). However, unlike the observational study we chose as a historical control, the present study was a prospective, multicenter study that used a pre-specified protocol.
A systematic review comparing RPN with LPN carried out by Choi et al. showed 23 studies, and they showed that the average warm ischemia time among studies of RPN ranged from 18 to 35.5 min. Three of 11 studies had no conversions to open surgery or radical nephrectomy, and only one study had no positive surgical margin. 9 In the present study, the mean warm ischemia time was 19 min (Table 2) , and just two of the 14 studies had a shorter warm ischemia time than the present study. Furthermore, there were no conversions to open or laparoscopic surgery and no positive surgical margins. These results suggest that RPN in Japan has similar performance to that reviewed systematically by Choi et al.
9
RPN is an effective method for treating patients with renal cancer. In the present study, 90% of patients achieved a warm ischemia time within 25 min, and there was an extremely low percentage of patients who underwent conversion to open or laparoscopic surgery, or had an excision stump. The procedure also has a low level of invasiveness, and it can radically cure the characteristics of cancer and preserve renal function simultaneously. We expect that RPN will become widely used in Japan in the future, even though this procedure is costly.
